Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer

Abstract Gas therapy has emerged as a promising approach for treating cancer, with gases like NO, H2S, and CO showing positive effects. Among these, NO is considered a key gas molecule with significant potential in stopping cancer progression. However, due to its high reactivity and short half-life,...

Full description

Saved in:
Bibliographic Details
Main Authors: Yaqin Tang, Qiyu Li, Ziwei Zhou, Huayang Bai, Nianting Xiao, Jing Xie, Chong Li
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-024-02929-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850062047116525568
author Yaqin Tang
Qiyu Li
Ziwei Zhou
Huayang Bai
Nianting Xiao
Jing Xie
Chong Li
author_facet Yaqin Tang
Qiyu Li
Ziwei Zhou
Huayang Bai
Nianting Xiao
Jing Xie
Chong Li
author_sort Yaqin Tang
collection DOAJ
description Abstract Gas therapy has emerged as a promising approach for treating cancer, with gases like NO, H2S, and CO showing positive effects. Among these, NO is considered a key gas molecule with significant potential in stopping cancer progression. However, due to its high reactivity and short half-life, delivering NO directly to tumors is crucial for enhancing cancer treatment. NO-driven nanomedicines (NONs) have been developed to effectively deliver NO donors to tumors, showing great progress in recent years. This review provides an overview of the latest advancements in NO-based cancer nanotherapeutics. It discusses the types of NO donors used in current research, the mechanisms of action behind NO therapy for cancer, and the different delivery systems for NO donors in nanotherapeutics. It also explores the potential of combining NO donors with other treatments for enhanced cancer therapy. Finally, it examines the future prospects and challenges of using NONs in clinical settings for cancer treatment. Graphical Abstract
format Article
id doaj-art-a2568be3efff40fab72ee36d41ceb7c7
institution DOAJ
issn 1477-3155
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj-art-a2568be3efff40fab72ee36d41ceb7c72025-08-20T02:50:02ZengBMCJournal of Nanobiotechnology1477-31552024-11-0122113610.1186/s12951-024-02929-zNitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancerYaqin Tang0Qiyu Li1Ziwei Zhou2Huayang Bai3Nianting Xiao4Jing Xie5Chong Li6Chongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of TechnologyChongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of TechnologyChongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of TechnologyChongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of TechnologyChongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of TechnologyChongqing Key Laboratory of Medicinal Chemistry and Molecular Pharmacology, Chongqing University of TechnologyCollege of Pharmaceutical Sciences, Southwest UniversityAbstract Gas therapy has emerged as a promising approach for treating cancer, with gases like NO, H2S, and CO showing positive effects. Among these, NO is considered a key gas molecule with significant potential in stopping cancer progression. However, due to its high reactivity and short half-life, delivering NO directly to tumors is crucial for enhancing cancer treatment. NO-driven nanomedicines (NONs) have been developed to effectively deliver NO donors to tumors, showing great progress in recent years. This review provides an overview of the latest advancements in NO-based cancer nanotherapeutics. It discusses the types of NO donors used in current research, the mechanisms of action behind NO therapy for cancer, and the different delivery systems for NO donors in nanotherapeutics. It also explores the potential of combining NO donors with other treatments for enhanced cancer therapy. Finally, it examines the future prospects and challenges of using NONs in clinical settings for cancer treatment. Graphical Abstracthttps://doi.org/10.1186/s12951-024-02929-zNitric oxideSynergistic nanomedicineCancer therapyResponsive nanoparticles
spellingShingle Yaqin Tang
Qiyu Li
Ziwei Zhou
Huayang Bai
Nianting Xiao
Jing Xie
Chong Li
Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer
Journal of Nanobiotechnology
Nitric oxide
Synergistic nanomedicine
Cancer therapy
Responsive nanoparticles
title Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer
title_full Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer
title_fullStr Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer
title_full_unstemmed Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer
title_short Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer
title_sort nitric oxide based multi synergistic nanomedicine an emerging therapeutic for anticancer
topic Nitric oxide
Synergistic nanomedicine
Cancer therapy
Responsive nanoparticles
url https://doi.org/10.1186/s12951-024-02929-z
work_keys_str_mv AT yaqintang nitricoxidebasedmultisynergisticnanomedicineanemergingtherapeuticforanticancer
AT qiyuli nitricoxidebasedmultisynergisticnanomedicineanemergingtherapeuticforanticancer
AT ziweizhou nitricoxidebasedmultisynergisticnanomedicineanemergingtherapeuticforanticancer
AT huayangbai nitricoxidebasedmultisynergisticnanomedicineanemergingtherapeuticforanticancer
AT niantingxiao nitricoxidebasedmultisynergisticnanomedicineanemergingtherapeuticforanticancer
AT jingxie nitricoxidebasedmultisynergisticnanomedicineanemergingtherapeuticforanticancer
AT chongli nitricoxidebasedmultisynergisticnanomedicineanemergingtherapeuticforanticancer